InsiderTrades.com logo

OVID Insider Trading

Insider Ownership Percentage: 7.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Ovid Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Ovid Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ovid Therapeutics Share Price & Price History

Current Price: $2.83
Price Change: ▲ Price Increase of +0.025 (0.89%)
As of 08/24/2026 01:33 PM ET

This chart shows the closing price history over time for OVID up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ovid Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2025Margaret A. AlexanderCOOBuy6,810$0.73$4,971.3034,935View SEC Filing Icon  
3/18/2024Jeremy M LevinCEOBuy18,248$2.76$50,364.483,616,715View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ovid Therapeutics (NASDAQ:OVID)

72.24% of Ovid Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OVID by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ovid Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/21/2026Braidwell LP5,919,464$15.92M0.6%N/A3.031%Search for SEC Filing on Google Icon
8/21/2026Velan Capital Investment Management LP130,000$0.35M0.2%-18.8%0.067%Search for SEC Filing on Google Icon
8/20/2026Two Sigma Securities LLC71,487$0.19M0.0%+182.3%0.037%Search for SEC Filing on Google Icon
8/19/2026Wellington Management Group LLP103,400$0.28M0.0%N/A0.053%Search for SEC Filing on Google Icon
8/18/2026Empowered Funds LLC91,234$0.25M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/18/2026Stonepine Capital Management LLC21,300$57.30M0.0%N/A0.011%Search for SEC Filing on Google Icon
8/17/2026Bank of America Corp DE409,490$1.10M0.0%N/A0.210%Search for SEC Filing on Google Icon
8/15/2026Jupiter Topco LLC20,741,234$55.90M0.0%N/A11.113%Search for SEC Filing on Google Icon
8/14/2026ADAR1 Capital Management LLC7,417,479$19.95M0.9%N/A3.974%Search for SEC Filing on Google Icon
8/14/2026Parkman Healthcare Partners LLC197,947$0.53M0.1%N/A0.106%Search for SEC Filing on Google Icon
8/14/2026Legal & General Group Plc14,858$40K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/14/2026The Manufacturers Life Insurance Company 40,910$0.11M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/13/2026Cibc World Market Inc.218,851$0.59M0.0%N/A0.117%Search for SEC Filing on Google Icon
8/11/2026E Fund Management Co. Ltd.19,286$52K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/7/2026BlackRock Inc.10,823,480$29.12M0.0%N/A5.799%Search for SEC Filing on Google Icon
8/7/2026Deutsche Bank AG149,391$0.40M0.0%N/A0.080%Search for SEC Filing on Google Icon
8/6/2026Bank of New York Mellon Corp416,318$1.12M0.0%N/A0.223%Search for SEC Filing on Google Icon
8/6/2026Focus Partners Advisor Solutions LLC20,000$54K0.0%N/A0.011%Search for SEC Filing on Google Icon
8/6/2026State of Wyoming53,438$0.14M0.0%N/A0.029%Search for SEC Filing on Google Icon
7/8/2026Assenagon Asset Management S.A.17,544$47K0.0%-92.3%0.009%Search for SEC Filing on Google Icon
5/19/2026Bank of America Corp DE290,432$0.65M0.0%+49.0%0.220%Search for SEC Filing on Google Icon
5/19/2026Janus Henderson Group PLC10,714,000$23.73M0.0%N/A8.124%Search for SEC Filing on Google Icon
5/19/2026Ally Bridge Group NY LLC2,818,459$6.26M5.1%+57.9%2.137%Search for SEC Filing on Google Icon
5/18/2026ADAR1 Capital Management LLC4,544,113$10.09M0.6%+6.0%3.446%Search for SEC Filing on Google Icon
5/15/2026OMERS ADMINISTRATION Corp100,100$0.22M0.0%-20.1%0.076%Search for SEC Filing on Google Icon
5/15/2026Affinity Asset Advisors LLC10,636,318$23.61M1.2%+48.8%8.065%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC1,104,300$2.45M0.0%-25.6%0.837%Search for SEC Filing on Google Icon
5/14/2026Sei Investments Co.328,924$0.73M0.0%N/A0.249%Search for SEC Filing on Google Icon
5/14/2026Walleye Capital LLC443,362$0.98M0.0%-16.3%0.336%Search for SEC Filing on Google Icon
5/14/2026State of Wyoming22,171$49K0.0%N/A0.017%Search for SEC Filing on Google Icon
4/27/2026Simplify Asset Management Inc.130,813$0.29M0.0%N/A0.099%Search for SEC Filing on Google Icon
4/20/2026Assenagon Asset Management S.A.227,742$0.51M0.0%-63.1%0.173%Search for SEC Filing on Google Icon
4/17/2026Total Clarity Wealth Management Inc.20,975$47K0.0%-26.7%0.016%Search for SEC Filing on Google Icon
4/17/2026Sovereign Financial Group Inc.30,000$67K0.0%+200.0%0.023%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.33,308$54K0.0%N/A0.047%Search for SEC Filing on Google Icon
2/18/2026ADAR1 Capital Management LLC4,285,000$6.99M0.5%+33,256.7%6.017%Search for SEC Filing on Google Icon
2/18/2026Ikarian Capital LLC247,558$0.40M0.0%-77.4%0.348%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd87,874$0.14M0.0%+217.2%0.123%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC1,339,465$2.18M0.0%+35.8%1.881%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.325,000$0.53M0.0%-48.0%0.456%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC155,741$0.25M0.0%-68.0%0.219%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC4,285,000$6.99M0.5%+33,256.7%6.017%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC192,496$0.31M0.0%-78.2%0.270%Search for SEC Filing on Google Icon
2/17/2026Ally Bridge Group NY LLC1,785,000$2.91M3.0%N/A2.507%Search for SEC Filing on Google Icon
2/17/2026RA Capital Management L.P.10,714,000$17.46M0.2%N/A15.046%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.3,492,000$5.69M0.0%+158.7%4.904%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.127,459$0.21M0.0%N/A0.179%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC39,034$64K0.0%-66.0%0.055%Search for SEC Filing on Google Icon
2/16/2026OMERS ADMINISTRATION Corp125,300$0.20M0.0%N/A0.176%Search for SEC Filing on Google Icon
2/16/2026Eventide Asset Management LLC4,285,000$6.99M0.1%N/A6.017%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP1,271,487$2.07M0.0%+62.3%1.786%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC530,020$0.86M0.0%-11.2%0.744%Search for SEC Filing on Google Icon
2/13/2026Affinity Asset Advisors LLC7,150,000$11.65M0.7%+169.8%10.041%Search for SEC Filing on Google Icon
2/13/2026AWM Investment Company Inc.899,200$1.47M0.1%N/A1.263%Search for SEC Filing on Google Icon
2/13/2026State Street Corp276,533$0.45M0.0%+21.8%0.388%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN720,848$1.18M0.0%-1.4%1.012%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC883,867$1.44M0.0%+270.7%1.241%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC1,484,478$2.42M0.0%-26.4%2.085%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.3,571,000$5.31M0.0%N/A5.015%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC30,000$49K0.0%+150.0%0.042%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.170,457$0.28M0.0%+497.7%0.239%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC672,004$1.10M0.0%+3.7%0.944%Search for SEC Filing on Google Icon
2/2/2026Total Clarity Wealth Management Inc.28,600$47K0.0%N/A0.040%Search for SEC Filing on Google Icon
1/12/2026Benin Management CORP19,000$31K0.0%N/A0.027%Search for SEC Filing on Google Icon
1/9/2026Assenagon Asset Management S.A.618,019$1.01M0.0%-33.2%0.868%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd25,277$33K0.0%-65.3%0.035%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC202,978$0.26M0.0%N/A0.285%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC986,293$1.28M0.0%-6.3%1.385%Search for SEC Filing on Google Icon
11/17/2025Integrated Wealth Concepts LLC52,900$69K0.0%N/A0.074%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE362,707$0.47M0.0%+2,333.0%0.509%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC486,877$0.63M0.0%N/A0.684%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC883,154$1.15M0.0%N/A1.240%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP341,134$0.44M0.0%N/A0.480%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC114,923$0.15M0.0%-48.0%0.162%Search for SEC Filing on Google Icon
11/13/2025Kennedy Capital Management LLC1,106,638$1.44M0.0%-26.3%1.556%Search for SEC Filing on Google Icon
11/13/2025Private Advisor Group LLC25,600$33K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/10/2025Persistent Asset Partners Ltd46,040$60K0.0%N/A0.065%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP265,993$0.35M0.0%-64.2%0.374%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.2,820,813$3.67M0.0%+7.0%3.967%Search for SEC Filing on Google Icon
11/4/2025TLS Advisors LLC18,858$26K0.1%-97.2%0.027%Search for SEC Filing on Google Icon
10/17/2025Apollon Wealth Management LLC27,500$36K0.0%N/A0.039%Search for SEC Filing on Google Icon
10/7/2025Assenagon Asset Management S.A.924,576$1.20M0.0%+112.2%1.300%Search for SEC Filing on Google Icon
8/15/2025Rosalind Advisors Inc.500,000$0.17M0.1%N/A0.703%Search for SEC Filing on Google Icon
8/15/2025Rubric Capital Management LP478,533$0.16M0.0%-91.0%0.673%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC142,597$47K0.0%N/A0.201%Search for SEC Filing on Google Icon
8/14/2025Velan Capital Investment Management LP160,000$53K0.1%+64.9%0.225%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP164,721$54K0.0%N/A0.232%Search for SEC Filing on Google Icon
8/13/2025Kennedy Capital Management LLC1,502,329$0.50M0.0%-13.3%2.113%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC643,335$0.21M0.0%-51.7%0.905%Search for SEC Filing on Google Icon
8/1/2025Y Intercept Hong Kong Ltd160,306$53K0.0%N/A0.225%Search for SEC Filing on Google Icon
7/11/2025Assenagon Asset Management S.A.435,620$0.14M0.0%-22.3%0.613%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC2,088,046$0.65M0.0%+12.8%2.936%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%Search for SEC Filing on Google Icon
5/16/2025Jacobs Levy Equity Management Inc.200,593$63K0.0%-31.2%0.282%Search for SEC Filing on Google Icon
5/16/2025Adage Capital Partners GP L.L.C.1,150,000$0.36M0.0%+15.0%1.617%Search for SEC Filing on Google Icon
5/14/2025Affinity Asset Advisors LLC667,516$0.21M0.0%N/A0.939%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC119,113$37K0.0%N/A0.168%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd93,154$29K0.0%N/A0.131%Search for SEC Filing on Google Icon
4/15/2025Assenagon Asset Management S.A.560,830$0.18M0.0%+699.9%0.789%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ovid Therapeutics logo
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial; OV825, has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Read More on Ovid Therapeutics

Today's Range

Now: $2.83
Low: $2.67
High: $2.83

50 Day Range

MA: $2.53
Low: $2.22
High: $2.93

52 Week Range

Now: $2.83
Low: $1.05
High: $3.11

Volume

362,731 shs

Average Volume

2,444,339 shs

Market Capitalization

$551.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21

Who are the company insiders with the largest holdings of Ovid Therapeutics?

Ovid Therapeutics' top insider shareholders include:
  1. Jeremy M Levin (CEO)
  2. Margaret A Alexander (COO)
  3. Amit Rakhit (CMO)
  4. Douglas E Williams (Director)
  5. Jason Tardio (COO)
  6. Karen Bernstein (Director)
  7. Pharmaceutical Co Ltd Takeda (Major Shareholder)
Learn More about top insider investors at Ovid Therapeutics.

Who are the major institutional investors of Ovid Therapeutics?

Ovid Therapeutics' top institutional investors include:
  1. Jupiter Topco LLC — 11.11%
  2. BlackRock Inc. — 5.80%
  3. ADAR1 Capital Management LLC — 3.97%
  4. Braidwell LP — 3.03%
  5. Bank of New York Mellon Corp — 0.22%
  6. Bank of America Corp DE — 0.21%
Learn More about top institutional investors of Ovid Therapeutics stock.

Which institutional investors are selling Ovid Therapeutics stock?

During the last quarter, OVID stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Velan Capital Investment Management LP

Which institutional investors are buying Ovid Therapeutics stock?

Within the last quarter, OVID stock was purchased by institutional investors including:
  1. Jupiter Topco LLC
  2. BlackRock Inc.
  3. ADAR1 Capital Management LLC
  4. Braidwell LP
  5. Bank of New York Mellon Corp
  6. Bank of America Corp DE
  7. Cibc World Market Inc.
  8. Parkman Healthcare Partners LLC

Ovid Therapeutics Active Insiders

Margaret A Alexander
Margaret A Alexander
President & Chief Executive Officer
Amit Rakhit
Amit Rakhit
CMO